Literature DB >> 7811224

Thyroid dysfunction in HIV infection.

M Lambert1.   

Abstract

During infection with HIV, overt clinical or biochemical thyroid dysfunctions are rare. When present, thyroid failure generally results from the destruction of the thyroid gland by opportunistic infections such as Pneumocystis carinii, or tumoural processes such as KS. Less frequently, hypothalamic-pituitary failure due to central nervous system infections is involved. Some cases of thyroiditis with thyrotoxicosis or hypothyroidism due to Pneumocystis carinii have also been reported. Subtle alterations of thyroid function tests are more common in HIV infection and are sometimes already detectable in the early phase of the disease. Contrary to what is observed in severe non-thyroidal illnesses, the low T3 syndrome and the sick euthyroid syndrome are less marked; these changes are mainly present in the final stage of the disease, when anorexia and weight loss occur, and indicate a poor outcome. Unique abnormalities of thyroid function indices have also been recently documented. A progressive elevation in serum TBG--but not in other binding proteins such as CBG and SHBG--accompanying the decline of the CD4 lymphocyte count, and associated with a concomitant increase in the serum T4 value, has been reported. An unusual prolonged maintenance of normal T3 levels with a paradoxical decrease in serum rT3 values has also been recognized. Finally, a hypothyroid-like regulation of the pituitary-thyroid axis, possibly directed to limit hypermetabolism in HIV infection, has been observed. The recognition of these particular thyroid profiles is of clinical importance as serum TBG appears to be a specific marker of the progression of HIV infection and serum T3 a reliable prognostic indicator for AIDS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7811224     DOI: 10.1016/s0950-351x(05)80303-9

Source DB:  PubMed          Journal:  Baillieres Clin Endocrinol Metab        ISSN: 0950-351X


  8 in total

1.  Thyroid screening in HIV-infected patients with antiretroviral therapy.

Authors:  Margit Hatzl; Angela Öllinger; Maria Geit; Klaus Wiesinger; Kristina Angerbauer; Josef Auböck; Michael Gabriel
Journal:  Wien Klin Wochenschr       Date:  2015-03-05       Impact factor: 1.704

2.  Neurosyphilis manifesting with unilateral visual loss and hyponatremia: a case report.

Authors:  Katrin Milger; Vera Fleig; Anke Kohlenberg; Thomas Discher; Jürgen Lohmeyer
Journal:  BMC Infect Dis       Date:  2011-01-15       Impact factor: 3.090

3.  Human immunodeficiency virus, diabetes mellitus and thyroid abnormalities: Should we be screening?

Authors:  Somasundram Pillay; Davashni Pillay; Deepak Singh; Romashan Pillay
Journal:  South Afr J HIV Med       Date:  2020-11-09       Impact factor: 2.744

Review 4.  Neuroendocrine-immune interactions in rheumatoid arthritis: mechanisms of glucocorticoid resistance.

Authors:  Marni N Silverman; Esther M Sternberg
Journal:  Neuroimmunomodulation       Date:  2008-07-29       Impact factor: 2.492

5.  Thyroid dysfunction in human immunodeficiency virus-infected children and its correlation with CD4(+) T lymphocyte count.

Authors:  Satyakumar Thongam; Sunibala Keithelakpam; Tomba Y Singh; Ranbir L Singh; Amuba M Singh; Salam Ranabir
Journal:  Indian J Endocrinol Metab       Date:  2015 Mar-Apr

Review 6.  Abnormalities of Thyroid Hormone Metabolism during Systemic Illness: The Low T3 Syndrome in Different Clinical Settings.

Authors:  Arnaldo Moura Neto; Denise Engelbrecht Zantut-Wittmann
Journal:  Int J Endocrinol       Date:  2016-10-10       Impact factor: 3.257

Review 7.  Thyroid Diseases and Thyroid Asymptomatic Dysfunction in People Living With HIV.

Authors:  Cristina Micali; Ylenia Russotto; Benedetto Maurizio Celesia; Laura Santoro; Andrea Marino; Giovanni Francesco Pellicanò; Giuseppe Nunnari; Emmanuele Venanzi Rullo
Journal:  Infect Dis Rep       Date:  2022-09-01

8.  Prevalence and Influencing Factors of Thyroid Dysfunction in HIV-Infected Patients.

Authors:  Shujing Ji; Changzhong Jin; Stefan Höxtermann; Wolfgang Fuchs; Tiansheng Xie; Xiangyun Lu; Haibo Wu; Linfang Cheng; Adriane Skaletz-Rorowski; Norbert H Brockmeyer; Nanping Wu
Journal:  Biomed Res Int       Date:  2016-04-20       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.